Anwar Abdelnaser

1.0k total citations · 2 hit papers
44 papers, 637 citations indexed

About

Anwar Abdelnaser is a scholar working on Molecular Biology, Health, Toxicology and Mutagenesis and Cancer Research. According to data from OpenAlex, Anwar Abdelnaser has authored 44 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Health, Toxicology and Mutagenesis and 9 papers in Cancer Research. Recurrent topics in Anwar Abdelnaser's work include MicroRNA in disease regulation (4 papers), Pesticide Exposure and Toxicity (4 papers) and Cancer-related molecular mechanisms research (4 papers). Anwar Abdelnaser is often cited by papers focused on MicroRNA in disease regulation (4 papers), Pesticide Exposure and Toxicity (4 papers) and Cancer-related molecular mechanisms research (4 papers). Anwar Abdelnaser collaborates with scholars based in Egypt, Germany and United States. Anwar Abdelnaser's co-authors include Hassan Mohamed El-Said Azzazy, Hassan A. N. El‐Fawal, Soad M. Nasr, Sherif Ashraf Fahmy, Siva S. Panda, Adel S. Girgis, Mohamed S. Bekheit, Mona F. Said, Mohamed M. Elmazar and Tarek S. Ibrahim and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Anwar Abdelnaser

40 papers receiving 625 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Decoding the Role of CYP450 Enzymes in Metabolism and Disease: A Comprehensive Review

2024 43 citations Mohamed Ali Hussein, Anwar Abdelnaser et al. Biomedicines profile →
From contamination to detection: The growing threat of heavy metals

2025 25 citations Anwar Abdelnaser et al. Heliyon profile →

Peers

Countries citing papers authored by Anwar Abdelnaser

Since Specialization

Citations

This map shows the geographic impact of Anwar Abdelnaser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anwar Abdelnaser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anwar Abdelnaser more than expected).

Fields of papers citing papers by Anwar Abdelnaser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anwar Abdelnaser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anwar Abdelnaser. The network helps show where Anwar Abdelnaser may publish in the future.

Co-authorship network of co-authors of Anwar Abdelnaser

This figure shows the co-authorship network connecting the top 25 collaborators of Anwar Abdelnaser. A scholar is included among the top collaborators of Anwar Abdelnaser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anwar Abdelnaser. Anwar Abdelnaser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-term Outcomes and Prognostic Impact of Residual Cancer Burden After Intensified Neoadjuvant Therapy in High-risk Prostate Cancer 2025 ·European Urology ·Praful Ravi, Lucia Kwak, Andrés Acosta, (unknown), Wanling Xie, Anwar Abdelnaser, David J. Einstein, Peter Chang, Andrew A. Wagner, Rana R. McKay, Adam S. Kibel, Mary‐Ellen Taplin	1
2	44P Potential combination of anti-CD-47 and natural compounds to harness calreticulin/CD47 immune checkpoint in triple-negative breast cancer patients 2025 ·ESMO Open ·(unknown), Anwar Abdelnaser, (unknown), Amira Abdel Motaal, Nanis G. Allam, R.A. Youness	1
3	Gut Microbiota Secondary Metabolites: Key Roles in GI Tract Cancers and Infectious Diseases 2025 ·Biomedicines ·(unknown), (unknown), Mohamed Sherif, (unknown), (unknown), (unknown), Anwar Abdelnaser	10
4	From contamination to detection: The growing threat of heavy metals breakdown → 2025 ·Heliyon ·(unknown), (unknown), (unknown), (unknown), Anwar Abdelnaser	25
5	Cracking the code: lncRNA-miRNA-mRNA integrated network analysis unveiling lncRNAs as promising non-invasive NAFLD biomarkers toward precision diagnosis 2025 ·Computational Biology and Chemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Mohamed Ali Hussein, (unknown), (unknown), (unknown), Nashwa El‐Khazragy, Anwar Abdelnaser	1
6	Toxic sprays, fragile brains: assessing pesticides exposure and disparities on neurodevelopment 2025 ·Neuroscience ·(unknown), (unknown), (unknown), (unknown), Anwar Abdelnaser	0
7	The impact of the exposome on cytochrome P450-mediated drug metabolism 2025 ·Frontiers in Pharmacology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Anwar Abdelnaser	0
8	The Impact of Microplastics in Food and Drugs on Human Health: A Review of the MENA Region 2025 ·International Journal of Environmental Research and Public Health ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Anwar Abdelnaser	4
9	Leveraging machine learning in precision medicine to unveil organochlorine pesticides as predictive biomarkers for thyroid dysfunction 2025 ·Scientific Reports ·(unknown), Mohamed Ali Hussein, (unknown), (unknown), Tamer Shoeib, Anwar Abdelnaser	2
10	Unveiling the Potential of Cannabinoids in Multiple Sclerosis and the Dawn of Nano-Cannabinoid Medicine 2024 ·Pharmaceutics ·(unknown), (unknown), (unknown), Walaa A. Abbas, (unknown), (unknown), (unknown), Anwar Abdelnaser	4
11	Decoding the Role of CYP450 Enzymes in Metabolism and Disease: A Comprehensive Review breakdown → 2024 ·Biomedicines ·(unknown), (unknown), (unknown), (unknown), Mohamed Ali Hussein, (unknown), (unknown), (unknown), Anwar Abdelnaser	43
12	Anti-inflammatory potential of aspergillus unguis SP51-EGY: TLR4-dependent effects & chemical diversity via Q-TOF LC-HRMS 2024 ·BMC Biotechnology ·Soad M. Nasr, (unknown), (unknown), Mohamed S. Abdel‐Aziz, Walid Fayad, Anwar Abdelnaser, Faten K. Abd El-Hady	1
13	New NSAID Conjugates as Potent and Selective COX-2 Inhibitors: Synthesis, Molecular Modeling and Biological Investigation 2023 ·Molecules ·(unknown), Siva S. Panda, Adel S. Girgis, (unknown), Mona F. Said, Anwar Abdelnaser, Soad M. Nasr, Mohamed S. Bekheit, (unknown), Horrick Sharma, Margaret Wade, Swapnil Sharma, (unknown)	13
14	Coping with Water Stress: Ameliorative Effects of Combined Treatments of Salicylic Acid and Glycine Betaine on the Biometric Traits and Water-Use Efficiency of Onion (Allium cepa) Cultivated under Deficit Drip Irrigation 2023 ·Biomolecules ·Muziri Mugwanya, Fahad Kimera, Anwar Abdelnaser, Hani Sewilam	2
15	A Novel Electrochemical Differentiation between Exosomal-RNA of Breast Cancer MCF7 and MCF7/ADR-Resistant Cells 2023 ·Pharmaceuticals ·(unknown), Ehab N. El Sawy, Anwar Abdelnaser	4
16	Impact of HepG2 Cells Glutathione Depletion on Neutral Sphingomyelinases mRNA Levels and Activity 2023 ·Current Issues in Molecular Biology ·(unknown), Hatem Tallima, Hassan Mohamed El-Said Azzazy, Anwar Abdelnaser	0
17	Cannabinoids and Multiple Sclerosis: A Critical Analysis of Therapeutic Potentials and Safety Concerns 2023 ·Pharmaceutics ·(unknown), (unknown), Anwar Abdelnaser	9
18	Development of Isatin‐Based Schiff Bases Targeting VEGFR‐2 Inhibition: Synthesis, Characterization, Antiproliferative Properties, and QSAR Studies 2022 ·ChemMedChem ·(unknown), Siva S. Panda, Adel S. Girgis, (unknown), Mona F. Said, Mohamed S. Bekheit, Anwar Abdelnaser, Soad M. Nasr, Walid Fayad, Ahmed A. F. Soliman, Rajeev Sakhuja, Tarek S. Ibrahim, Zakaria K. Abdel‐Samii, Amany M. M. Al‐Mahmoudy	15
19	Climate change, human health, and the exposome: Utilizing OMIC technologies to navigate an era of uncertainty 2022 ·Frontiers in Public Health ·(unknown), Sherouk M. Tawfik, (unknown), (unknown), (unknown), (unknown), Walaa A. Abbas, Anwar Abdelnaser	13
20	Hepigenetics: A Review of Epigenetic Modulators and Potential Therapies in Hepatocellular Carcinoma 2020 ·BioMed Research International ·(unknown), Hassan A. N. El‐Fawal, Anwar Abdelnaser	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact